Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 7/20 | 0.56 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | REN | P00797 | 1/20 | 0.48 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.47 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.47 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16344009 | 1.00 | ACE (0.56) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL16344004 | 1.00 | ACE (0.56) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL19024592 | 0.98 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL5035740 | 0.98 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL10757058 | 0.98 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL10537390 | 0.98 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL15650373 | 0.98 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL10406629 | 0.98 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL21853572 | 0.98 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL9362232 | 0.98 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 656 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117084949-B | Physical sun-screening composition with skin barrier repairing effect and preparation method thereof | 绽妍生物科技股份有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119997927-A | Composition for caring keratin materials | 莱雅公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119968193-A | Composition for caring keratin materials | 莱雅公司 | 2025-05-09 | — | — | CN | claimed |
| CN-116421534-B | Physical sun cream for sensitive muscles and preparation method thereof | 绽妍生物科技股份有限公司 | 2025-02-28 | — | — | CN | claimed |
| US-20250057746-A1 | OIL-IN-WATER TYPE D-PHASE EMULSION COMPOSITION WITH EXCELLENT EMULSION STABILITY | LG H&H CO., LTD. (KR) | 2025-02-20 | — | — | US | claimed |
| CN-119097586-A | Cosmetic composition containing negative oxygen ions | 丽水北森生物科技有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-119074571-A | Metal oxidation sun protection agent | 阿迈瑞斯公司 | 2024-12-06 | — | — | CN | claimed |
| CN-118717621-A | Whitening efficacy composition, whitening essence, whitening milk and preparation method of whitening milk | 卡莱丽化妆品有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-118434399-A | Oil-in-water type D-phase emulsion composition having excellent emulsion stability | 株式会社 LG 生活健康 | 2024-08-02 | — | — | CN | claimed |
| WO-2024065606-A1 | COMPOSITION FOR CARING FOR KERATIN MATERIALS | L'OREAL (FR) | 2024-04-04 | — | — | WO | claimed |
| CN-113398008-A | Soothing skin-care gel capable of achieving continuous cooling and preparation method thereof | 广州市百好博有限公司 | 2021-09-17 | — | — | CN | claimed |
| WO-2021155115-A1 | METAL OXIDE SUNSCREEN FORMULATIONS | Amyris, Inc. (US) | 2021-08-05 | — | — | WO | claimed |
| CN-109498523-B | Anti-chapping skin care product and preparation thereof | 广东润洁日化有限公司 | 2021-07-30 | — | — | CN | claimed |
| CN-110859772-A | Composition with seven whitening effects and preparation method and application thereof | 泉后(广州)生物科技研究院有限公司 | 2020-03-06 | — | — | CN | claimed |
| US-8367122-B2 | Control of blood vessel physiology to treat skin disorders | BIOCHEMICS, INC. (US) | 2013-02-05 | — | — | US | claimed |
| US-20100003353-A1 | Control of Blood Vessel Physiology to Treat Skin Disorders | BIOCHEMICS, INC. (US) | 2010-01-07 | — | — | US | claimed |
| EP-2094229-A2 | COSMETIC COMPOSITION COMPRISING A PROLINE DERIVATIVE AND/OR A SALT OF THE SAID DERIVATIVE | L'OREAL (FR) | 2009-09-02 | — | — | EP | claimed |
| WO-2008061990-A2 | COSMETIC COMPOSITION COMPRISING A PROLINE DERIVATIVE AND/OR A SALT OF THE SAID DERIVATIVE | L'OREAL (FR) | 2008-05-29 | — | — | WO | claimed |
| EP-1759688-A1 | Cosmetic method for the care of greasy skin and kit therefor | L'Oréal (FR) | 2007-03-07 | — | — | EP | claimed |
| WO-2003035023-A1 | COSMETIC COMPOSITION CONTAINING A DHEA DERIVATIVE AND A SOOTHING AGENT | L'OREAL (FR) | 2003-05-01 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250057746-A1 | OIL-IN-WATER TYPE D-PHASE EMULSION COMPOSITION WITH EXCELLENT EMULSION STABILITY | NAPEPLD, AQP1, PRR12 | ACE 918/4885ACE2 1333/4885L3MBTL1 4204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.